Trump to Sign ‘One of the Most Consequential’ EOs Yet That Will Slash Prescription Drug Prices by up to 80%

Former President Donald Trump is preparing to unveil a new executive order that’s drawing attention from both supporters and critics. The measure is expected to focus on lowering prescription drug costs, a topic that has long been a point of national debate.

Former President Donald Trump has announced a sweeping executive order aimed at cutting prescription drug prices by as much as 80 percent, calling it “one of the most consequential executive orders in our country’s history.” The move, set to be formally signed at the White House on Monday, was revealed in a statement on TruthSocial.

At the core of the policy is a “Most Favored Nation” pricing rule, which would require that Americans pay no more for prescription medications than the lowest price charged in any other country. Trump argued this change would end the long-standing practice of Americans paying far more for the same drugs than people overseas, despite the medications being made by the same companies in the same facilities.

He criticized pharmaceutical companies for offloading research and development costs onto U.S. consumers, whom he referred to as being treated like “suckers.” Trump also took aim at Democrats, claiming they have protected drug companies in exchange for political contributions—a charge he said would not be tolerated under his leadership or by the Republican Party.

Trump estimated that under this executive order, drug prices in the U.S. would drop by 30 to 80 percent almost immediately, while prices in other countries would likely increase to balance global markets. He positioned this as a step toward fairness for American patients who, for years, have shouldered inflated healthcare costs.

The announcement comes at a time when healthcare affordability remains a serious challenge for many Americans. Recent data shows that more than 91 million adults struggle to access adequate healthcare due to high costs. Even among the 305 million Americans with insurance, millions still face crippling out-of-pocket expenses, and over 70 million avoid seeking medical care altogether due to financial concerns.

The timing also follows significant price hikes by major drug manufacturers. Companies like Novo Nordisk, Eli Lilly, AstraZeneca, and Pfizer have raised prices on essential medications—some by as much as 8 percent—making life-saving treatments increasingly unaffordable for patients.

Trump’s executive order aims to address these rising costs and reduce the burden of medical debt, which affects four in ten U.S. adults. He emphasized that this policy could save the country trillions in healthcare spending while giving American families some much-needed relief.

Scroll down to leave a comment and share your thoughts.